Your browser is no longer supported. Please, upgrade your browser.
Settings
AVGR [NASD]
Avinger, Inc.
Index- P/E- EPS (ttm)-0.23 Insider Own0.30% Shs Outstand95.38M Perf Week-19.03%
Market Cap51.07M Forward P/E- EPS next Y-0.22 Insider Trans-0.07% Shs Float94.32M Perf Month-31.08%
Income-21.10M PEG- EPS next Q-0.05 Inst Own12.20% Short Float1.11% Perf Quarter-42.70%
Sales10.50M P/S4.86 EPS this Y85.40% Inst Trans5.36% Short Ratio0.61 Perf Half Y-55.26%
Book/sh0.12 P/B4.25 EPS next Y4.30% ROA-57.40% Target Price2.25 Perf Year57.99%
Cash/sh0.23 P/C2.21 EPS next 5Y- ROE-135.50% 52W Range0.28 - 2.67 Perf YTD15.88%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-80.90% Beta1.63
Dividend %- Quick Ratio3.40 Sales past 5Y-3.90% Gross Margin35.30% 52W Low82.14% ATR0.06
Employees75 Current Ratio4.00 Sales Q/Q4.30% Oper. Margin- RSI (14)28.77 Volatility11.63% 10.41%
OptionableNo Debt/Eq1.03 EPS Q/Q21.00% Profit Margin- Rel Volume0.52 Prev Close0.55
ShortableYes LT Debt/Eq1.03 Earnings- Payout- Avg Volume1.72M Price0.51
Recom2.00 SMA20-27.28% SMA50-29.98% SMA200-51.61% Volume904,340 Change-7.31%
Jun-29-21Initiated B. Riley Securities Buy $2.50
Mar-09-18Initiated Ladenburg Thalmann Buy
Apr-12-17Downgrade Oppenheimer Outperform → Perform
Apr-11-17Downgrade Canaccord Genuity Buy → Hold $4.30 → $1
Dec-29-15Downgrade Dougherty & Company Buy → Neutral
May-08-15Reiterated Dougherty & Company Buy $16 → $18
Apr-29-15Initiated Dougherty & Company Buy $16
Feb-24-15Initiated Oppenheimer Outperform $15
Feb-24-15Initiated Canaccord Genuity Buy $18
Nov-17-21 12:45PM  
08:30AM  
Nov-11-21 04:01PM  
Nov-04-21 03:01PM  
06:00AM  
Oct-29-21 08:30AM  
Oct-07-21 11:00AM  
08:45AM  
Sep-08-21 08:45AM  
Sep-03-21 07:38AM  
Aug-16-21 08:00AM  
Aug-10-21 04:01PM  
Aug-09-21 07:30AM  
Jul-27-21 04:00PM  
Jul-22-21 09:20AM  
Jul-06-21 08:30AM  
Jun-28-21 08:45AM  
Jun-13-21 02:37PM  
Jun-07-21 08:00AM  
May-25-21 08:30AM  
May-17-21 08:00AM  
May-09-21 03:35AM  
May-06-21 04:01PM  
02:45PM  
Apr-26-21 08:30AM  
Apr-21-21 08:00AM  
Apr-15-21 08:00AM  
Apr-08-21 08:30AM  
Mar-11-21 04:50PM  
04:01PM  
02:30PM  
08:35AM  
Mar-10-21 10:08AM  
Mar-02-21 05:17PM  
08:00AM  
Feb-03-21 01:50PM  
08:00AM  
Feb-02-21 11:25AM  
Jan-28-21 04:45PM  
Jan-27-21 08:30AM  
Jan-26-21 08:30AM  
Jan-19-21 08:30AM  
Jan-15-21 12:04PM  
08:30AM  
Jan-08-21 11:05AM  
10:17AM  
Jan-06-21 04:05PM  
Dec-24-20 11:59PM  
Dec-23-20 04:50PM  
Dec-11-20 07:30AM  
Dec-04-20 08:30AM  
Dec-01-20 08:30AM  
Nov-10-20 04:01PM  
02:30PM  
Nov-06-20 12:00PM  
Nov-05-20 08:00AM  
Oct-28-20 08:30AM  
Oct-19-20 07:00AM  
Sep-15-20 12:00PM  
Sep-11-20 10:26AM  
08:30AM  
Sep-01-20 01:05PM  
Aug-31-20 10:50AM  
Aug-25-20 12:00PM  
Aug-21-20 10:55AM  
Aug-20-20 08:45PM  
Aug-17-20 11:17AM  
Aug-11-20 10:05AM  
Aug-10-20 12:20PM  
Aug-06-20 12:30PM  
Aug-04-20 12:00PM  
Aug-03-20 08:05PM  
Jul-30-20 04:01PM  
Jul-27-20 08:30AM  
Jul-09-20 11:50AM  
Jun-30-20 08:03PM  
Jun-29-20 12:15PM  
Jun-26-20 02:20PM  
Jun-23-20 08:40PM  
Jun-10-20 07:52AM  
May-29-20 12:42PM  
May-28-20 12:00PM  
May-26-20 11:54AM  
May-20-20 08:30AM  
May-13-20 04:01PM  
May-07-20 09:00AM  
May-06-20 12:00PM  
Apr-30-20 11:17AM  
Apr-27-20 09:25PM  
Apr-17-20 12:00PM  
Apr-15-20 09:00AM  
Mar-13-20 11:17AM  
Mar-05-20 04:05PM  
02:30PM  
Feb-27-20 08:00AM  
Feb-25-20 08:30AM  
Feb-04-20 08:00AM  
Jan-31-20 04:01PM  
Jan-30-20 08:30AM  
Jan-28-20 08:05PM  
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CULLEN JAMESDirectorNov 30Sale0.5718410569,820Nov 30 07:09 PM
CULLEN JAMESDirectorNov 24Sale0.62322070,004Nov 26 04:07 PM